Nokes D J, Williams J R, Butler A R
Wellcome Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, UK.
Vet Microbiol. 1995 May;44(2-4):333-50. doi: 10.1016/0378-1135(95)00027-8.
Despite an increase in global measles vaccine coverage from under 20% in 1980 to around 80% in 1990, measles remains a major cause of morbidity and mortality world-wide. This paper addresses a number of issues relating to efforts to control measles, namely, (i) at the global level, how might we assess the impact of measles vaccination on the incidence of infection and associated disease, and, (ii), at the strategic level, how can we utilise an understanding of the transmission dynamics of childhood viral infections to aid the design of optimal immunisation programmes? Based on WHO vaccine coverage data, and organising countries according to similarities in demographic and epidemiological parameters, an age-structured model of measles transmission is used to capture the non-linear dynamics of infection and mass vaccination and to generate projections of the impact of measles immunization world-wide. The results provide a crude indication of the percentage reduction in measles cases by year 2000 (compared with no immunization) and suggest an approximately 70% reduction in cases over all ages, and 77% reduction in cases under 5 years (where there is the greatest risk of case fatality); these suggest that WHO targets for 1995 are unlikely to be achieved. In the second part of the paper, examples are given to illustrate the usefulness of a modelling approach in evaluating measles immunization policy. The introduction of MMR vaccine in the UK in 1988 has resulted in measles incidence falling to an all time low and attention has turned to the requirements of elimination. A realistic age structured model, validated using extensive serological data, is used to compare the merits of single or two dose strategies. Based upon recent estimates of vaccine efficacy (90%) and coverage (92% by end of second year of life) it is suggested that a two-dose policy with a pre-school second dose given irrespective of vaccine history is required to prevent the build up of susceptibles to epidemic proportions in the longer term. In a second example, prompted by the success of the campaign approach to polio and measles elimination in Central and South America, simple models are used to explore and quantify the process by which pulse vaccination programmes (i.e. repeated application across a wide age range) act to control transmission.
尽管全球麻疹疫苗接种覆盖率从1980年的不到20%提高到了1990年的约80%,但麻疹仍是全球发病和死亡的主要原因。本文探讨了与麻疹控制努力相关的若干问题,即:(i)在全球层面,我们如何评估麻疹疫苗接种对感染发病率及相关疾病的影响;以及(ii)在战略层面,我们如何利用对儿童期病毒感染传播动态的理解来辅助设计最佳免疫规划?基于世界卫生组织的疫苗接种覆盖率数据,并根据人口统计学和流行病学参数的相似性对各国进行分类,采用了一个年龄结构的麻疹传播模型来捕捉感染和大规模疫苗接种的非线性动态,并生成全球麻疹免疫影响的预测。结果粗略显示了到2000年麻疹病例减少的百分比(与未进行免疫接种相比),表明所有年龄段的病例约减少70%,5岁以下病例减少77%(该年龄段病例死亡风险最高);这些结果表明世界卫生组织1995年的目标不太可能实现。在本文的第二部分,给出了一些例子来说明建模方法在评估麻疹免疫政策中的有用性。1988年英国引入麻疹、腮腺炎和风疹联合疫苗(MMR疫苗)后,麻疹发病率降至历史最低水平,人们的注意力转向了消除麻疹的要求。使用一个基于广泛血清学数据验证的现实年龄结构模型来比较单剂量或两剂量策略的优缺点。根据最近对疫苗效力(90%)和接种覆盖率(到生命第二年年底为92%)的估计,建议采用两剂量策略,即无论疫苗接种史如何,在学龄前给予第二剂疫苗,以防止易感人群在长期内累积到流行程度。在第二个例子中,受中美洲和南美洲脊髓灰质炎和麻疹消除运动方法成功的启发,使用简单模型来探索和量化脉冲式疫苗接种计划(即在广泛年龄范围内重复接种)控制传播的过程。